Brief: Cytomx Therapeutics Q1 Net Income USD 23.525 Million
12/05/2025 12:27
May 12 (Reuters) - CytomX Therapeutics Inc CTMX.O: CYTOMX THERAPEUTICS Q1 NET INCOME USD 23.525 MILLION CYTOMX THERAPEUTICS Q1 OPERATING EXPENSES USD 28.296 MILLION CYTOMX THERAPEUTICS Q1 OPERATING INCOME USD 22.621 MILLION CYTOMX THERAPEUTICS Q1 REVENUE USD 50.917 MILLION CYTOMX THERAPEUTICS Q1 CASH & INVESTMENTS USD 79.9 MILLION CYTOMX THERAPEUTICS Q1 EPS USD 0.27 Source text: ID:nGNX3JYYsw Further company coverage: CTMX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on CytomX Therapeutics
See all newsCytomX Q2 revenue misses, partly hurt by lower research activities in the Astellas collaboration
CytomX Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Cytomx Therapeutics Announces Appointment Of Charles Fuchs, M.D., M.P.H., To The Board Of Directors
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway